Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk.
|
Nat Genet
|
2010
|
17.89
|
2
|
Common variants at 10 genomic loci influence hemoglobin A₁(C) levels via glycemic and nonglycemic pathways.
|
Diabetes
|
2010
|
4.07
|
3
|
Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals.
|
PLoS Genet
|
2012
|
3.21
|
4
|
Genome-wide association identifies nine common variants associated with fasting proinsulin levels and provides new insights into the pathophysiology of type 2 diabetes.
|
Diabetes
|
2011
|
2.21
|
5
|
A genome-wide association search for type 2 diabetes genes in African Americans.
|
PLoS One
|
2012
|
1.72
|
6
|
[Prevalence of the metabolic syndrome (ATP-III criteria). Population-based study of rural and urban areas in the Spanish province of Segovia].
|
Med Clin (Barc)
|
2005
|
1.69
|
7
|
Genetic structure of the Spanish population.
|
BMC Genomics
|
2010
|
1.34
|
8
|
The FTO obesity gene. Genotyping and gene expression analysis in morbidly obese patients.
|
Obes Surg
|
2008
|
1.31
|
9
|
Serum circulating microRNA profiling for identification of potential type 2 diabetes and obesity biomarkers.
|
PLoS One
|
2013
|
1.24
|
10
|
Lipodystrophy and metabolic syndrome in HIV-infected patients treated with antiretroviral therapy.
|
Metabolism
|
2006
|
1.10
|
11
|
An SNP in the adiponectin gene is associated with decreased serum adiponectin levels and risk for impaired glucose tolerance.
|
Obes Res
|
2005
|
1.02
|
12
|
Geographic variations of the International Diabetes Federation and the National Cholesterol Education Program-Adult Treatment Panel III definitions of the metabolic syndrome in nondiabetic subjects.
|
Diabetes Care
|
2006
|
1.02
|
13
|
Which obesity index best explains prevalence differences in type 2 diabetes mellitus?
|
Obesity (Silver Spring)
|
2007
|
1.00
|
14
|
The membrane-spanning 4-domains, subfamily A (MS4A) gene cluster contains a common variant associated with Alzheimer's disease.
|
Genome Med
|
2011
|
0.98
|
15
|
Central adiposity determines prevalence differences of the metabolic syndrome.
|
Obes Res
|
2003
|
0.98
|
16
|
Lipid accumulation product: a powerful marker of metabolic syndrome in healthy population.
|
Eur J Endocrinol
|
2011
|
0.97
|
17
|
The association between leptin and left ventricular hypertrophy: a population-based cross-sectional study.
|
J Hypertens
|
2003
|
0.96
|
18
|
Ability of lipid accumulation product to identify metabolic syndrome in healthy men from Buenos Aires.
|
Diabetes Care
|
2009
|
0.95
|
19
|
Variant rs9939609 in the FTO gene is associated with obesity in an adult population from Spain.
|
Clin Endocrinol (Oxf)
|
2008
|
0.94
|
20
|
Common variants of the liver fatty acid binding protein gene influence the risk of type 2 diabetes and insulin resistance in Spanish population.
|
PLoS One
|
2012
|
0.92
|
21
|
WWOX gene is associated with HDL cholesterol and triglyceride levels.
|
BMC Med Genet
|
2010
|
0.88
|
22
|
Calpain-5 gene variants are associated with diastolic blood pressure and cholesterol levels.
|
BMC Med Genet
|
2007
|
0.86
|
23
|
K121Q PC-1 gene polymorphism is not associated with insulin resistance in a Spanish population.
|
Obes Res
|
2003
|
0.84
|
24
|
Metabolic syndrome, adiponectin, and cardiovascular risk in Spain (the Segovia study): impact of consensus societies criteria.
|
Metab Syndr Relat Disord
|
2013
|
0.83
|
25
|
The CAPN10 gene is associated with insulin resistance phenotypes in the Spanish population.
|
PLoS One
|
2008
|
0.83
|
26
|
A functional nonsynonymous toll-like receptor 4 gene polymorphism is associated with metabolic syndrome, surrogates of insulin resistance, and syndromes of lipid accumulation.
|
Metabolism
|
2009
|
0.83
|
27
|
Leptin and adipose tissue maldistribution in HIV-infected male patients with predominant fat loss treated with antiretroviral therapy.
|
J Acquir Immune Defic Syndr
|
2002
|
0.82
|
28
|
Interaction between Calpain 5, Peroxisome proliferator-activated receptor-gamma and Peroxisome proliferator-activated receptor-delta genes: a polygenic approach to obesity.
|
Cardiovasc Diabetol
|
2008
|
0.81
|
29
|
Is waist circumference an essential component of the metabolic syndrome?
|
Diabetes Care
|
2007
|
0.81
|
30
|
Endothelial nitric oxide synthase haplotypes are associated with features of metabolic syndrome.
|
Clin Chem
|
2006
|
0.80
|
31
|
Common haplotypes of the C-reactive protein gene and circulating leptin levels influence the interindividual variability in serum C-reactive protein levels. The Segovia study.
|
Thromb Haemost
|
2007
|
0.80
|
32
|
Risk factors associated with metabolic syndrome in type 2 diabetes mellitus patients according to World Health Organization, Third Report National Cholesterol Education Program, and International Diabetes Federation definitions.
|
Diabetes Metab Syndr Obes
|
2010
|
0.79
|
33
|
Common genetic variants of surfactant protein-D (SP-D) are associated with type 2 diabetes.
|
PLoS One
|
2013
|
0.79
|
34
|
Association analysis of urotensin II gene (UTS2) and flanking regions with biochemical parameters related to insulin resistance.
|
PLoS One
|
2011
|
0.79
|
35
|
[Diabetes mellitus, heart failure and mortality].
|
Med Clin (Barc)
|
2005
|
0.78
|
36
|
The Arg64 allele of the beta 3-adrenoceptor gene but not the -3826G allele of the uncoupling protein 1 gene is associated with increased leptin levels in the Spanish population.
|
Metabolism
|
2004
|
0.78
|
37
|
Association of ENPP1 (PC-1) K121Q polymorphism with obesity-related parameters in subjects with metabolic syndrome.
|
Clin Endocrinol (Oxf)
|
2007
|
0.78
|
38
|
Functional characterization of TLR4 +3725 G/C polymorphism and association with protection against overweight.
|
PLoS One
|
2012
|
0.78
|
39
|
Interaction of the -308G/A promoter polymorphism of the tumor necrosis factor-alpha gene with single-nucleotide polymorphism 45 of the adiponectin gene: effect on serum adiponectin concentrations in a Spanish population.
|
Clin Chem
|
2005
|
0.77
|
40
|
Molecular basis of insulin action.
|
Drug News Perspect
|
2007
|
0.76
|
41
|
Is the plasminogen activator inhibitor-1 gene a candidate gene predisposing to hypertension? Results from a population-based study in Spain.
|
J Hypertens
|
2007
|
0.76
|
42
|
[20th Scientific Symposium of the Lilly Foundation: Obesity today. Introduction].
|
Endocrinol Nutr
|
2013
|
0.75
|